2025-04-14 19:28:23
Latest Post
IPO-bound Belrise Industries Ltd completes strategic acquisition of H-One India Private Limited
Mitsu Chem Plast Eyes ₹ 1,000 Cr Revenue by 2028
Aurobindo Pharma receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
NHPC Ltd commissions commercial operation of 107.14 MW of 300 MW Karnisar Solar Power Plant
Nureca Limited's Manufacturing Subsidiary Secures US FDA Registration
Stock Report
Central Bank of India posts net profit of Rs. 234.78 crores in Q1 FY2022-23
Posted On : 2022-07-25 13:17:44( TIMEZONE : IST )
Central Bank of India has reported Standalone financial results for the period ended June 30, 2022.
Financial Results (Q1 FY2023) - QoQ Comparison
The company has reported total income of Rs. 6357.48 crores during the period ended June 30, 2022 as compared to Rs. 6419.58 crores during the period ended March 31, 2022.
The company has posted net profit / (loss) of Rs. 234.78 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 310.31 crores for the period ended March 31, 2022.
The company has reported EPS of Rs. 0.27 for the period ended June 30, 2022 as compared to Rs. 0.36 for the period ended March 31, 2022.
| Financials | Q1 FY2023 | Q4 FY2022 | % Change |
| Total Income | ₹6357.48 crs | ₹6419.58 crs |  -0.97% |
| Net Profit | ₹234.78 crs | ₹310.31 crs | -24.34% |
| EPS | ₹0.27 | ₹0.36 | -25.00% |
Financial Results (Q1 FY2023) - YoY Comparison
The company has reported total income of Rs.6357.48 crores during the period ended June 30, 2022 as compared to Rs.6299.63 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs.234.78 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.205.58 crores for the period ended June 30, 2021.
The company has reported EPS of Rs.0.27 for the period ended June 30, 2022 as compared to Rs.0.30 for the period ended June 30, 2021.
| Financials | Q1 FY2023 | Q1 FY2022 | % Change |
| Total Income | ₹6357.48 crs | ₹6299.63 crs |  0.92% |
| Net Profit | ₹234.78 crs | ₹205.58 crs | 14.20% |
| EPS | ₹0.27 | ₹0.30 | -10.00% |
Asset Quality:
| Asset Quality | Q1 FY2023 | Q4 FY2022 | Q1 FY2022 |
| Gross NPA | ₹ 29001.63 crs | ₹28156.22 crs | ₹27891.70 crs |
| Gross NPA % | 14.90% | 14.84% | 15.92% |
| Net NPA | ₹6784.70 crs | ₹6675.17 crs | ₹7904.03 crs |
| Net NPA % | 3.93% | 3.97% | 5.09% |
Gross NPA was at ₹ 29001.63 crs in Q1 FY2023 against ₹ 27891.70 crs in Q1 FY2022. The same was at ₹ 28156.22 crs in Q4 FY2022.
Net NPA was at ₹ 6784.70 crs in Q1 FY2023 against ₹ 7904.03 crs in Q1 FY2022. The same was at ₹ 6675.17 crs in Q4 FY2022.
GNPA was at 14.90% of Gross advances as on June 30, 2022 as compared to 15.92% as on June 30, 2021 and 14.84% as of March 31, 2022.
Net NPA was at 3.93% of Gross advances as on June 30, 2022 as compared to 5.09% as on June 30, 2021 and 3.97% as of March 31, 2022.
| Ratios | Q1 FY2023 | Q4 FY2022 | Q1 FY2022 |
| RoA % | 0.27% | 0.36% | 0.24% |
| CAR (BASEL III) % | 13.33% | 13.84% | 13.01% |
Return on Average Assets (RoA) is at 0.27% for Q1 FY2023 against 0.36% in Q4 FY2022 and 0.24% in Q1 FY2022.
In Q1 FY2023, Bank's total Capital Adequacy Ratio (CAR) was at 13.33%, as compared to 13.84% in Q4 FY2022 and 13.01% in Q1 FY2022.
Shares of Central Bank of India was last trading in BSE at Rs. 18.50 as compared to the previous close of Rs. 18.60. The total number of shares traded during the day was 214986 in over 806 trades.
The stock hit an intraday high of Rs. 18.80 and intraday low of 18.40. The net turnover during the day was Rs. 3999877.00.
